Lipids Market

Global Lipids Market:

The global lipids market size reached US$ 10.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% during 2024-2032. The growing demand for healthy food and supplements, along with the rising need to add sufficient nutrition to the daily diet, is bolstering the market.

Lipids Market Analysis:

• Major Market Drivers: The rising interest in personalized medicine is inflating the need for lipid-based drug delivery systems, thereby propelling the market.
• Key Market Trends: The increasing awareness of functional ingredients is advancing the use of lipids in cosmetics and personal care items, which is acting as a significant growth-inducing factor.
• Competitive Landscape: Some of the major market companies include Archer Daniels Midland Company, BASF SE, Cargill Incorporated, Clover Corporation Limited, Croda International Plc, FrieslandCampina Ingredients, Kerry Group plc, Koninklijke DSM N.V., Nordic Naturals Inc., Omega Protein Corporation (Cooke Inc.), and Polaris, among many others.
• Geographical Trends: In Asia Pacific, rising vegan and vegetarian population, and Europe focuses on lipid-based pharmaceuticals. Moreover, North America is seeing growth in functional foods, and Latin America is expanding in cosmetic applications. At the same time, the Middle East and Africa witnessed increased use of lipids in personal care and food industries.
• Challenges and Opportunities: The limited availability of raw materials is hindering the market. However, innovations in alternative sourcing and improved extraction techniques will continue to strengthen the market over the forecasted period.
   

Lipids Market Trends:

Increasing Demand for Nucleic Acid Delivery

Lipids play a key role in delivering nucleic acids for therapies, as they enhance stability and bioavailability in drug formulations. In contrast, the market benefits from the rising development of lipid-based delivery systems, which is essential for safely transporting genetic material into target cells. For instance, in February 2024, Evonik partnered with the University of Mainz to commercialize randomized polyethylene glycols (rPEGs) for nucleic acid delivery. These specialized lipids, part of Evonik’s expanding drug delivery platform, aim to improve immunogenicity profiles for applications such as mRNA vaccines and gene therapies.

Expanding Cardiovascular Disease Management Solutions

Lipids are key in managing cholesterol and improving patient outcomes in cardiovascular care. Moreover, the growing focus on lipid therapies and clinical solutions to reduce cardiovascular risks drives the demand for improved lipid testing, management, and treatment options within healthcare systems. For instance, in May 2024, Health Innovation South West launched a new toolkit to enhance lipid services for cardiovascular disease patients. The Somerset Lipids Project, financed by the Collaborative Lipids Fund, led to expanded clinics, reduced wait times, and improved lipid management through targeted education and service redesign.

Advancements in Lipid Testing Standardization

Standardization in lipid testing improves the accuracy of cholesterol and lipid level measurements. The demand for consistent, reliable lipid tests is growing as healthcare shifts towards precision medicine, thereby helping healthcare providers better assess risks and tailor treatments for patients, supporting market expansion. For instance, in September 2024, the Association for Diagnostics & Laboratory Medicine (ADLM) released new guidelines to standardize lipid testing for cardiovascular care. This guidance aims to improve lipid test accuracy, covering cholesterol measurements, non-HDL-C, and LDL-C, and reducing fasting requirements, thereby enhancing patient care and testing accessibility.

Global Lipids Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, source, form, and application.

Breakup by Type:

• Omega-3 and Omega-6
• Phospholipids
• Medium Chain Triglycerides
• Sterols
   

The report has provided a detailed breakup and analysis of the market based on the type. This includes omega-3 and omega-6, phospholipids, medium chain triglycerides, and sterols.

Omega-3 and omega-6 fatty acids are essential lipids that support heart and brain health, and phospholipids are key components of cell membranes. At the same time, medium-chain triglycerides provide rapid energy, while sterols such as cholesterol, are vital for cell structure and hormone synthesis, thereby highlighting the diverse roles of lipids.

Breakup by Source:

• Plant
• Animal
   

The report has provided a detailed breakup and analysis of the market based on the source. This includes plant and animal.

Plant lipids, such as those from seeds and nuts, are typically rich in unsaturated fatty acids, promoting heart health. In contrast, animal lipids, found in meats and dairy, often contain saturated fats, thereby influencing cholesterol levels and overall health profiles.

Breakup by Form:

• Powder
• Liquid
   

The report has provided a detailed breakup and analysis of the market based on the form. This includes powder and liquid.

As per the lipids market outlook, it can be sourced in both powder and liquid forms. Furthermore, powdered lipids, like certain protein supplements, offer convenience for easy incorporation into diets, while liquid lipids, such as oils provide versatile culinary uses and essential fatty acids for health.

Breakup by Application:

• Dietary Supplements and Nutraceuticals
• Infant Formula
• Pharmaceutical
• Food Fortification
• Animal Nutrition
• Others
   

The report has provided a detailed breakup and analysis of the market based on the application. This includes dietary supplements and nutraceuticals, infant formula, pharmaceutical, food fortification, animal nutrition, and others.

Lipids play a vital role in dietary supplements and nutraceuticals, enhancing health benefits and nutrient absorption. Meanwhile, in infant formulas, they provide essential fatty acids for growth, and in pharmaceuticals, lipids facilitate drug delivery. At the same time, in food fortification and animal nutrition, they improve nutritional quality and overall health.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico and others), and the Middle East and Africa.

In the Asia Pacific region, the growing demand for healthy fats drives lipid consumption, particularly in cooking oils and supplements, and Europe emphasizes omega-3 fatty acids in health products. On the contrary, North America focuses on functional lipids for dietary enhancements, and Latin America is witnessing increased interest in natural lipid sources. Meanwhile, the Middle East and Africa are exploring lipids for both traditional cuisines and emerging health trends, thereby broadening their applications across various sectors and elevating the lipids market share.

Competitive Landscape:

The research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• Archer Daniels Midland Company
• BASF SE
• Cargill Incorporated
• Clover Corporation Limited
• Croda International Plc
• FrieslandCampina Ingredients
• Kerry Group plc
• Koninklijke DSM N.V.
• Nordic Naturals Inc.
• Omega Protein Corporation (Cooke Inc.)
• Polaris
   

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Lipids Market Recent Developments:

• September 2024: The Association for Diagnostics & Laboratory Medicine (ADLM) released new guidelines to standardize lipid testing for cardiovascular care. This guidance aims to improve lipid test accuracy, covering cholesterol measurements, non-HDL-C, LDL-C, and reducing fasting requirements.
• May 2024: Health Innovation South West launched a new toolkit to enhance lipid services for cardiovascular disease patients, financed by the Collaborative Lipids Fund, led to expanded clinics, reduced wait times, and improved lipid management through targeted education and service redesign.
• March 2024: CordenPharma introduced Lipid NanoParticle (LNP) Starter Kits for mRNA-based therapeutics. These kits include essential lipids for mRNA delivery and optimize LNP formulation, thereby ensuring efficient transfection across various cell types and applications, from R&D to clinical phases.

Lipids Market Report Scope:

Key Questions Answered in This Report

• How has the global lipids market performed so far, and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global lipids market growth?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the source?
• What is the breakup of the market based on the form?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global lipids market, and who are the key players?
• What is the degree of competition in the industry?

Key Benefits for Stakeholders:

• IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the lipids market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global lipids market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the lipids industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.